28353042|t|Beneficial Effects of Phyllanthus amarus Against High Fructose Diet Induced Insulin Resistance and Hepatic Oxidative Stress in Male Wistar Rats
28353042|a|Insulin resistance (IR) is a characteristic feature of obesity, type 2 diabetes mellitus, and cardiovascular diseases. Emerging evidence suggests that the high-fructose consumption is a potential and important factor responsible for the rising incidence of IR. The present study investigates the beneficial effects of aqueous extract of Phyllanthus amaru s (PAAE) on IR and oxidative stress in high-fructose (HF) fed male Wistar rats. HF diet (66% of fructose) and PAAE (200 mg/kg body weight/day) were given concurrently to the rats for a period of 60 days. Fructose-fed rats showed weight gain, hyperglycemia, hyperinsulinemia, impaired glucose tolerance, impaired insulin sensitivity, dyslipidemia, hyperleptinemia, and hypoadiponectinemia (P < 0.05) after 60 days. Co-administration of PAAE along with HF diet significantly ameliorated all these alterations. Regarding hepatic antioxidant status, higher lipid peroxidation and protein oxidation, lower reduced glutathione levels and lower activities of enzymatic antioxidants, and the histopathological changes like mild to severe distortion of the normal architecture as well as the prominence and widening of the liver sinusoids observed in the HF diet -fed rats were significantly prevented by PAAE treatment. These findings indicate that PAAE is beneficial in improving insulin sensitivity and attenuating metabolic syndrome and hepatic oxidative stress in fructose-fed rats.
28353042	0	18	Beneficial Effects	T080	C1280500
28353042	22	40	Phyllanthus amarus	T002	C0950041
28353042	49	67	High Fructose Diet	T168	C0012155
28353042	76	94	Insulin Resistance	T046	C0021655
28353042	99	123	Hepatic Oxidative Stress	T049	C0242606
28353042	127	131	Male	T032	C0086582
28353042	132	143	Wistar Rats	T015	C0034716
28353042	144	162	Insulin resistance	T046	C0021655
28353042	164	166	IR	T046	C0021655
28353042	199	206	obesity	T047	C0028754
28353042	208	232	type 2 diabetes mellitus	T047	C0011860
28353042	238	261	cardiovascular diseases	T047	C0007222
28353042	299	312	high-fructose	T109,T121	C0016745
28353042	313	324	consumption	T039	C1947907
28353042	330	339	potential	T080	C3245505
28353042	354	360	factor	T169	C1521761
28353042	381	397	rising incidence	T169	C0220888
28353042	401	403	IR	T046	C0021655
28353042	417	422	study	T062	C2603343
28353042	423	435	investigates	T169	C1292732
28353042	440	458	beneficial effects	T080	C1280500
28353042	462	477	aqueous extract	T167	C2828366
28353042	481	498	Phyllanthus amaru	T002	C0950041
28353042	502	506	PAAE	T167	C2828366
28353042	511	513	IR	T046	C0021655
28353042	518	534	oxidative stress	T049	C0242606
28353042	538	551	high-fructose	T109,T121	C0016745
28353042	553	555	HF	T109,T121	C0016745
28353042	561	565	male	T032	C0086582
28353042	566	577	Wistar rats	T015	C0034716
28353042	579	586	HF diet	T168	C0012155
28353042	609	613	PAAE	T167	C2828366
28353042	653	665	concurrently	T079	C0205420
28353042	673	677	rats	T015	C0034716
28353042	703	715	Fructose-fed	T080	C0205556
28353042	716	720	rats	T015	C0034716
28353042	728	739	weight gain	T033	C0043094
28353042	741	754	hyperglycemia	T047	C0020456
28353042	756	772	hyperinsulinemia	T047	C0020459
28353042	774	800	impaired glucose tolerance	T047	C0271650
28353042	802	830	impaired insulin sensitivity	T046	C0920563
28353042	832	844	dyslipidemia	T047	C0242339
28353042	846	861	hyperleptinemia	T047	C0012634
28353042	867	886	hypoadiponectinemia	T047	C2675519
28353042	913	930	Co-administration	T061	C1533734
28353042	934	938	PAAE	T167	C2828366
28353042	950	957	HF diet	T168	C0012155
28353042	994	1005	alterations	T078	C1515926
28353042	1017	1024	hepatic	T029	C0205054
28353042	1025	1043	antioxidant status	T044	C1148564
28353042	1052	1070	lipid peroxidation	T044	C0023775
28353042	1075	1092	protein oxidation	T044	C1159301
28353042	1100	1119	reduced glutathione	T034	C0034917
28353042	1131	1147	lower activities	T038	C3890174
28353042	1151	1173	enzymatic antioxidants	T121	C0003402
28353042	1183	1208	histopathological changes	T169	C0243140
28353042	1229	1239	distortion	T080	C2919017
28353042	1313	1328	liver sinusoids	T023	C0227523
28353042	1345	1352	HF diet	T168	C0012155
28353042	1358	1362	rats	T015	C0034716
28353042	1395	1399	PAAE	T167	C2828366
28353042	1400	1409	treatment	T061	C0087111
28353042	1440	1444	PAAE	T167	C2828366
28353042	1472	1491	insulin sensitivity	T046	C0920563
28353042	1508	1526	metabolic syndrome	T047	C0025517
28353042	1531	1555	hepatic oxidative stress	T049	C0242606
28353042	1559	1571	fructose-fed	T080	C0205556
28353042	1572	1576	rats	T015	C0034716